Results of a comparative analysis of magnetic resonance imaging-targeted versus three-dimensional transrectal ultrasound prostate biopsies: Size does matter

OBJECTIVE - The aim of this study was to compare the detection rate of clinically significant disease in magnetic resonance imaging (MRI)-targeted biopsies versus three-dimensional transrectal ultrasound (3D TRUS)-guided biopsies according to prostate size.

METHODS - The study compared 120 consecutive biopsy-naïve men who underwent 3D TRUS-guided systematic biopsy to 120 consecutive men who underwent MRI-targeted biopsy. Stratifications based on tertiles were used for assessing interactions between prostate volume and rates of detection of significant cancer.

RESULTS - Older age, higher prostate-specific antigen level, lower prostate volume, increased number of cores and MRI-targeted biopsy were independent predictors of prostate cancer detection in the entire cohort on logistic regression. Clinically significant cancer detection rates were significantly higher in the MRI-targeted group than in the 3D TRUS-guided biopsy group (48. 7% vs 29. 4%, p = 0. 002). When stratified according to prostate volume, these rates were significantly higher only in the third tertile group (volume > 50 cm(3)) for MRI-targeted biopsy compared to 3D TRUS-guided biopsy (56% vs 22%, p = 0. 003).

CONCLUSIONS - MRI-targeted biopsies increased the detection rate of clinically significant prostate cancer only in patients with enlarged prostates compared to the 3D TRUS.

Go “Beyond the Abstract” - Read an article commentary written by the authors

Scandinavian journal of urology. 2016 Jan 12 [Epub ahead of print]

Alexandre Peltier, Fouad Aoun, Simone Albisinni, Quentin Marcelis, Dam Ledinh, Marianne Paesmans, Marc Lemort, Roland van Velthoven

a Department of Urology , Jules Bordet Institute, Université Libre de Bruxelles , Brussels , Belgium ;, a Department of Urology , Jules Bordet Institute, Université Libre de Bruxelles , Brussels , Belgium ;, a Department of Urology , Jules Bordet Institute, Université Libre de Bruxelles , Brussels , Belgium ;, a Department of Urology , Jules Bordet Institute, Université Libre de Bruxelles , Brussels , Belgium ;, a Department of Urology , Jules Bordet Institute, Université Libre de Bruxelles , Brussels , Belgium ;, b Department of Statistics , Jules Bordet Institute, Université Libre de Bruxelles , Brussels , Belgium ;, c Department of Radiology , Jules Bordet Institute, Université Libre de Bruxelles , Brussels , Belgium. , a Department of Urology , Jules Bordet Institute, Université Libre de Bruxelles , Brussels , Belgium ;

PubMed

E-Newsletters

Newsletter subscription

Free Daily and Weekly newsletters offered by content of interest

The fields of GU Oncology and Urology are rapidly advancing. Sign up today for articles, videos, conference highlights and abstracts from peer-review publications by disease and condition delivered to your inbox and read on the go.

Subscribe